Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
AbbVie’s Five Biggest Priorities, Apart From Allergan
Jul 26 2019
•
By
Joseph Haas
AbbVie hopes Skyrizi will be a growth-driver post-Humira
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Earnings
More from Business